According to the National Kidney Foundation, 26 million adults in the United States have chronic kidney disease with millions of others at risk (National Kidney Foundation, 2012). Over time, this disorder will become progressively worse, and patients will eventually experience a loss of renal function. Early detection and prevention is key for patients with this disorder. For this reason, it is important for you, as the provider, to be aware of various signs, symptoms, and risk factors of chronic kidney disease. In this Assignment, you explore the disorder including the role that patient history, physical exams, and diagnostics play in diagnosis and treatment.
About Chronic Kidney Disease - The National Kidney Feb 2017 Chronic kidney disease (CKD) is a condition characterized by a gradual loss of kidney function over time To read more about kidney function,Chronic kidney disease - WikipediaChronic kidney disease (CKD), also known as chronic renal disease, is progressive loss in kidney function over a period of months or years The symptoms ofOverview - Chronic kidney disease - Mayo ClinicAug 2016 Chronic kidney disease, also called chronic kidney failure, describes the gradual loss of kidney function Your kidneys filter wastes and excessChronic Kidney Disease: Stages 4, 3, 2 and Feb 2016 Read about chronic kidney disease (CKD) stages (4, 3, 2, and 1), symptoms, diet, treatment, signs, and diagnosis Chronic kidney diseaseChronic kidney disease - NHS ChoicesFind out what chronic kidney disease (CKD) is, including what the symptoms are, how it s diagnosed and how it can be treated
(2013) Jaensh S 22(5) p801-803 looked at the effect of CKD on the Spec fPL test and found "Cats with azotaemia and cats with renal insufficiency had significantly higher mean SPEC fPL than cats without azotaemia or cats with pre-renal azotaemia... Cats with renal insufficiency had an elevated SPEC fPL in 50 % of cases, with 14% marginally elevated and 36% consistent with pancreatitis." The study concludes "This paper reveals increased pancreatic-specific lipase in cats with renal insufficiency, but not pre-renal azotaemia, and suggests a significant effect of renal insufficiency on serum pancreatic-specific lipase concentrations."
In one older study, (2000) Elliott J, Rawlings JM, Markwell PJ, Barber PJ 41 pp235-42, 29 cats were fed a reduced protein, low phosphorus therapeutic kidney diet, while a further 21 cats did not eat this diet. Some of the cats (presumably in both groups) were also given phosphorus binders. The cats fed the therapeutic kidney diet survived longer than the other cats, but it is not clear whether this was due to the reduction in phosphorus intake rather than the reduction in protein intake. The study concluded "Feeding a veterinary clinical diet (with intestinal phosphate binders where necessary) specifically formulated for feline renal failure was associated with a highly significant beneficial effect on survival of cats presenting with naturally occurring stable CKD. This is the first prospective dietary study involving naturally occurring feline CKD cases where survival from first diagnosis has been assessed."
Write a 2- to 3-page paper that addresses the following:
•Describe the clinical presentation of chronic kidney disease.
•Explain how you might diagnose a patient with chronic kidney disease including the role that patient history, physical exams, and diagnostics play in diagnosis.
•Explain implications of potential treatment options for this disease including prescribed drugs.
•Describe how patient factors might impact the diagnosis and treatment of patients with chronic kidney disease.
The programme confirmedÂ that informing and empowering patients in primary care can have a real impact on the long term management of kidney is is on articles related to the early identification of kidney disease; prevention or delay in progression of kidney disease; the multidisciplinary case management of patients with chronic kidney disease or kidney failure, organ effects of kidney disease; epidemiology and outcomes research in chronic kidney disease; benefits and complications of the primary treatment methods, dialysis and transplantation; technical aspects of the delivery of uremia therapy; care of the critically ill patient with kidney failure in the intensive care setting; new therapies for kidney failure; and health care research in chronic kidney al care issues stress the multidisciplinary team approach to the care of kidney patients
In June 2016, the NIDDK convened a meeting of an external expert panel to review the past performance and future plans of both CKiD and the NIDDK-sponsored Chronic Renal Insufficiency Cohort (CRIC) study. Based on study findings to date, and recommendations of the expert panel, the NIDDK would like to continue the CKiD study for an additional five years, with some modifications to the current protocol.
The NIDDK-funded Chronic Kidney Disease in Children (CKiD) study has been a rich source of data in regard to pediatric CKD progression, risk factors for progression, and the onset of comorbidities. We have learned, for example, that the rate of progression is significantly different in those whose underlying disease is glomerular compared to those with nonglomerular disease (generally urologic or congenital, and the majority of pediatric CKD). We have also learned that cardiovascular disease is a major comorbidity, with a rate significantly different from that of the general pediatric population. Additionally, the currently funded NEPTUNE and CureGN studies are giving us insight into specific glomerular disease etiologies. However, these are all observational cohort studies. The European ESCAPE trial showed that ACEI/ARBs were efficacious for delaying CKD progression in children when aggressive blood pressure (BP) targets were used (50 percentile), but such a study has not been undertaken in the U.S. The BP 50 percentile is not generally the clinical target used for BP control in the U.S., and it is unclear whether that target is appropriate in the more heterogeneous US population. Growth, metabolic bone disease, anemia, acid-base imbalances, and cardiovascular disease all remain problematic for children with CKD. We document these comorbidities, but do not appear to be making a significant impact in treating them.
About Chronic Kidney Disease - The National Kidney Feb 2017 Chronic kidney disease (CKD) is a condition characterized by a gradual loss of kidney function over time To read more about kidney function,Chronic Kidney Disease: Stages 4, 3, 2 and Feb 2016 Read about chronic kidney disease (CKD) stages (4, 3, 2, and 1), symptoms, diet, treatment, signs, and diagnosis Chronic kidney diseaseChronic Kidney Disease: Causes, Symptoms and Treatments Jan 2016 Chronic kidney disease, also known as chronic renal failure, chronic renal disease, or chronic kidney failure, is a slow progressive loss ofChronic Kidney Disease-Topic Overview - WebMDIs this topic for you? This topic provides information about chronic kidney diseaseChronic kidney disease - WikipediaChronic kidney disease (CKD), also known as chronic renal disease, is progressive loss in kidney function over a period of months or years The symptoms of
Kidney Failure (ESRD) Causes, Symptoms, & If the damage to your kidneys continues to get worse and your kidneys are less and less able to do their job, you have chronic kidney disease Kidney failure isChronic kidney disease - NHS ChoicesFind out what chronic kidney disease (CKD) is, including what the symptoms are, how it s diagnosed and how it can be treatedChronic Kidney Disease: Practice Essentials, Jul 2016 Chronic kidney disease (CKD)or chronic renal failure (CRF), as it was historically termedis a term that encompasses all degrees of
The goals outlined in this FOA were developed in part, from the NIDDK sponsored workshop "Pilot Clinical Trials in Pediatric Chronic Kidney Disease" held on July 22, 2016: